Abstract
INTRODUCTION
Infection with Helicobacter pylori (H. pylori) causes chronic inflammation of the gastric mucosa with progression to severe complications in a subset of patients [1] [2] [3] . The determinants for the magnitude of inflammation and progression to complication include H. pylori with its bacterial virulence factors, host genetic background and environmental factors. H. pylori virulence factors facilitate colonization (urease, flagella and catalase) and induce inflammation (OipA, NapA, DupA, IceA, VacA and CagA) of the gastric mucosa [4, 5] . CagA and VacA are the most relevant proinflammatory factors and are closely related to peptic ulcer disease (PUD) as well as gastric cancer (GC) [6] [7] [8] [9] . CagA is the principal protein encoded in the complex of the cytotoxin associated gene pathogenicity island (cag PAI), which is shuttled from H. pylori into gastric epithelial cells through the type Ⅳ bacterial secretion system [7, 8] . Intracellularly, CagA undergoes tyrosine phosphorylation by Src and Abl kinases to interact with several host proteins, influence their activity and subsequently alter morphological properties of the host cells [10] [11] [12] [13] . CagA protein stimulates expression of inflammatory cytokine interleukin-8 (IL-8) in gastric epithelial cells by activating nuclear factor-kB and leads to increased inflammation of the gastric mucosa [14] . Overall, H. pylori cagA+ strains are associated with an increased risk of gastric cancer compared to cagAstrains [15] . The oncogenic role of CagA is further supported by in vivo experiments in mice, where transgenic cagA expression in stomach leads to gastric epithelial hyperplasia, adenocarcinoma, myeloid leukemia and B-cell lymphoma [16] . One of the interesting features related to CagA is the induction of a systemic immune response to CagA and this in fact led to the discovery of this protein [17] . Infection with cagA+ strains and serological detection of anti-CagA antibodies have been associated with increased risk for PUD as well as for GC [18, 19] . A metaanalysis of 16 studies concludes that seropositivity for anti-CagA-IgG is associated with a 2.87-fold higher risk for gastric cancer development [20] . In earlier studies, Ando et al [21] found a significant correlation between anti-CagA-IgG and IL-8 expression in biopsy culture supernatant and described an association of anti-CagA-IgG with increased neutrophil infiltration and H. pylori density. Therefore, it has been suggested that screening for the cagA status of H. pylori may provide an additional advantage for identifying patients at high risk for gastric cancer development [20] . However, low levels of anti-CagA-IgG in subjects infected with cagA+ strains have been reported [22, 23] . H. pylori IgG seroprevalence in a large study in our center was 44.4%, and proportion anti-CagA-IgG positive was 43.3% [22] . In another prospective study on patients undergoing screening colonoscopy, we observed an even lower proportion (36.6%) of anti-CagA-IgG positivity [23] . In studies performed in various geographic regions of the world the CagA-seropositivity ranges from 35% to 80% [22] [23] [24] . The low number of CagAseropositivity in spite of the high prevalence of H. pylori cagA+ strains has not been explained. At present only few studies addressed this observation, however, systematic data are not yet available [25] [26] [27] .
In the present prospective study, we aimed to identify the factors related to serological reactivity or immune response to CagA.
MATERIALS AND METHODS

Study design
In a prospective study 413 patients were recruited between July 2011 and April 2014. Among those, 99 patients (98 patients of European descent) in total fulfilled the inclusion criteria such as microbiologically confirmed H. pylori infection with successful isolation and characterization of H. pylori strains and known H. pylori anti-CagA status ( Figure S1 ). Patients, with current or past history of non-gastric cancers or stomach surgery, acute bleeding, oral anticoagulation, immunosuppressive or antibiotic therapy (within the last 2 wk before entering the study) were excluded. The study was conducted according to the "World Medical Association Declaration of Helsinki -Ethical Principles for Medical Research Involving Human Subjects" and approved by the ethical board of the Otto-von-Guericke University (Study Number 80/11). All patients provided written informed consent. Blood samples were drawn and systematic biopsy protocol was completed during upper GI endoscopy at the Department of Gastroenterology, Hepatology and Infectious Diseases at the Otto-von-Guericke University of Magdeburg, Germany.
Biopsy protocol and histopathological assessment
During upper GI endoscopy, biopsies from antrum and corpus were collected for microbiology cultivation of H. pylori, rapid urease test (CLOtest, Kimberly Clark, United States), histological assessment and further molecular analyses. Histological evaluation was performed according to the updated Sydney protocol from five biopsies (two from each antrum and corpus and one from incisura angularis) [28, 29] . Following fixation, slides were stained with hematoxilin, eosin, PAS and modified Giemsa stain for H. pylori detection. Gastric cancer tumor tissues were characterized according to the International Classification of Diseases for Oncology and Lauren criteria.
Serological assessment of anti-H. pylori IgG and anti-
CagA-IgG
Serological assessment for H. pylori was performed using H. pylori IgG ELISA Kit (Biohit, Helsinki, Finland) and CagA IgG ELISA Kit (GENESIS Diagnostics, Cambridgeshire, Great Britain). Both tests exhibited a high sensitivity for detection of H. pylori infection in our region and have been validated in multiple studies in the past [22, 23] . 
H. pylori cultivation
Gastric biopsies were collected in 1.5 mL 0.9 vol% isotonic sodium chloride solution (Berlin-Chemie AG, Berlin, Germany) and immediately transported to the Institute of Medical Microbiology for further cultivation. Cultivation and identification of H. pylori was performed as described previously [30] . Positive cultures were harvested in 0.9 vol% isotonic sodium chloride solution, centrifuged at 13.000 rpm for 3 min and cell pellets were stored at -30 ℃ until further analysis.
Cell culturing with H. pylori
Six days before the experiment, frozen stocks of several H. pylori isolates from patients were inoculated on Columbia-agar-based medium that contained 10 vol% washed human erythrocytes and 10 vol% heat inactivated horse serum (purchased from the NRZ, Nationales Referenzzentrum Helicobacter Freiburg, Germany). Bacteria were cultivated under microaerophilic conditions at 37 ℃. The strain H. pylori ATCC ® BAA-1606™ (BCM300) was cultivated on selective agar plates (bioMérieux, Marcy l'Etoile, France) under the same conditions. After 3 d bacteria were removed into PBS and cultivated on fresh agar plates for another three days under the same conditions. For the experiments, bacteria were re-suspended in PBS (with Ca 2+ and Mg
2+
) and concentration (bacteria/mL) was determined by measuring the optical density (λ = 580 nm). (Table S1 ). Quality of qRT-PCR products was verified by melt curve analysis and agarose gel electrophoresis (see above). Expression data were analyzed using the 2 -ΔCt method.
CagA expression in vitro using Western blotting
Cell pellets were mixed with 2x Laemmli buffer (4% SDS, 20% glycerol, 120 mmol/L Tris-Cl (pH 6.8) and 0.02% bromphenol blue) and boiled for 10 min at 95 ℃. Thereafter, samples were separated using 10% SDS-polyacrylamide gel and transferred to a polyvinylidene difluoride membrane. Membranes were blocked with TBS buffer and incubated with antibodies as previously described [31] . and fresh antibiotic free medium was added. One well was harvested by trypsination (5 min, 37 ℃) and cell number was determined. Cells were infected with H. pylori at a "multiplicity of infection" of 100 for 24 h. Cell culture supernatant was removed, centrifuged at 13.000 rpm for 5 min and transferred into a new reaction tube. After cells were washed twice with PBS, cells were harvested, washed with PBS and cell pellet was stored at -80 ℃ until further analysis.
IL-8 quantification using ELISA
RESULTS
Clinical characteristic of patients with and without
CagA-IgG
Genomic DNA extraction of H. pylori and PCR methods
DNA extraction of H. pylori was performed using DNA Mini Kit (Qiagen, Hilden, Germany) following manufacturer's recommendations. Amplification of DNA was done in a T3 Thermocycler machine (Biometra, Goettingen, Germany) with 15 µL HotStar Taq Plus DNA Polymerase Mix (Qiagen, Hilden, Germany), 11.6 µL RNase-free water, 0.2 µL of each forward and reverse primer (50 µmol/L) and 3 µL H. pylori DNA. Seven primer sets were used for the study: cagA, EPIYA, vacA s, vacA m, glmM, cagE and virB11. The primer sequences and size of product are shown in Table S1 . The reactions were carried out as follows:
enzyme activation at 95 ℃ for 15 min, 40 cycles of denaturation at 95 ℃ for 30 s, annealing for 30 s, extension at 72 ℃ for 1 min followed by final extension at 72 ℃ for 10 min PCR products were analyzed by agarose gel electrophoresis, ethidium bromide staining and Hyperladder IV (Bioline, Luckenwalde, Germany) as molecular weight marker. E.A.S.Y RH system (Herolab, Wiesloch, Germany) was used for gel imaging.
Extraction of total RNA and quantitative RT-PCR
H. pylori total RNA was extracted using RNeasy Protect Bacteria Reagent and RNeasy Mini Kit (QIAGEN, Hilden, Germany) following manufacturer's recommendations. Total RNA of gastric specimens and AGS cells was isolated using RNeasy Plus Universal Mini Kit (QIAGEN, Hilden, Germany) following the manufacturer's recommendations (without gDNA Eliminator Solution). RNA concentration was determined spectrophotometrically by measuring absorbance at 260/280 nm (Biophotometer, Eppendorf, Hamburg, Germany). cDNA synthesis was performed in a 40 µL and demographical data are presented in Table 1 . Among different histological conditions, corpus predominant gastritis and chronic atrophic gastritis were more frequently found in the group of patients with seropositivity for anti-CagA-IgG. More patients with chronic non-active gastritis or patients without any inflammation were found in the anti-CagA-IgG negative group, suggesting the weaker Inflammation related to H. pylori infection. With further focus on the clinical phenotype, we observed a slightly higher polymophonuclear neutrophil infiltration in corpus and a more severe atrophy with intestinal metaplasia in antrum of patients with anti-CagA-IgG based on the mean Sydney Scores for corpus and antrum separately ( Figure 1 
Characteristics of H. pylori strains in patients with and without anti-CagA-IgG
It has been previously suggested that immune response to CagA may be dependent on H. pylori strain characteristics and its virulence factors. As expected all six patients in CagA-IgG-group had cagA-strains. All strains from patients with CagA-IgG+ had cagA+ strains ( Figure 2A ). Next, we speculated that CagA immune response may be further dependent on successful transcription of cagA mRNA. All strains in CagA-IgG+ group showed moderate or high cagA mRNA expression. At the same time 34 (56.7%) patients of the CagA-IgG-group had also positive cagA mRNA expression. We questioned if differences in EPIYA motifs or a missing Type Ⅳ secretion system could have an impact on production of CagA-IgG. A large proportion of the patients had an evidence for H. pylori with mixed EPIYA motifs and no specific differences were observed among CagA-IgG positive and negative groups ( Table 2) . As a surrogate for the presence of cagA pathogenicity island and type Ⅳ secretion system, we examined cagE (cagPAI marker) and virB11 (T4SS marker) expression in 54 patients of the cagA+ and CagA IgG negative group.
CagE was detectable in all tested H. pylori isolates, while only one strain was negative for virB11 (data not shown) further excluding the potentially missing T4SS.
It is well known that VacA and CagA are the main pro-inflammatory bacterial factors. It has been earlier hypothesized that vacA polymorphism may also be related to CagA seropositivity [25] . As shown in of H. pylori vacA virulence factor in immune response ( Figure 2B ).
H.pylori-induced inflammation in mucosa and in vitro model
CagA with functional TSS4 is known to induce IL-8 in vitro and in vivo. Having shown increased histological inflammation in subjects with anti-CagA-IgG, we questioned if this may correlate with H. pylori-related cytokine IL-8 in antrum mucosa. Independently of histological phenotype, IL-8 was significantly higher (about 2 fold) in patients with anti-CagA-IgG+ compared to anti-CagA-IgG-patients with CG (0.0082 ± 0.009 vs 0.0048 ± 0.004, P = 0.026) ( Figure 3A) . This, however, was not the case in mucosa from patients with GC and PUD, although the number of the patients was very small. We observed no correlation between IL-8 expression in mucosa and the level of anti-CagA-IgG. To confirm those strain-dependent observations, we performed in vitro analyses using H. pylori co-culture with AGS cell line. We randomly selected H. pylori strains with different strain characteristics including cagA mRNA expression, CagAIgG and vacA polymorphisms ( Table 3) 
CagA expression in vitro
Having shown that multiple factors may be related to seropositivity to CagA, we questioned if the H. pylori strains indeed a capable of expression of functional CagA protein (including its phosphorylated form) in AGS cells. For this purpose, we performed CagA Western blotting using bacterial pellets and AGS cells co-cultivated with H. pylori ( Table 3) . As expected, we found that the majority of H. pylori cagA+ strains with vacA s1m1 polymorphism indeed were capable of CagA protein expression independently to antiCagA-IgG positivity in host ( an additional level of evidence that anti-CagA-IgG is dependent on various bacterial and probably host factors but may not be useful as a biomarker for lesser pathogenic H. pylori infection.
Validation of CagA-IgG data
For the analysis of IgG response against CagA, we used well established ELISA-based method [22, 23] .
To confirm these results and to further evaluate seropositivity, we performed an independent analysis using Immunoblot based method to evaluate the seropositivity. Helicobacter ViraStripe ® IgG Kit includes, besides CagA, also various other Antigenpreparations such as VacA, p90, UreA, etc. Overall, there was a strong correlation between the two tests [r = 0.722 (95%CI: 0.6-0.81), P < 0.0001] ( Figure  S3A ). All samples with positivity in anti-CagA-IgG ELISA test (Omega Genesis) showed very strong signal in immunoblot with values above 200 ( Figure  S3B ). However, there were also several samples with positive signal in immunoblot and low values in ELISA, suggesting that certain samples with anti-CagA-IgG could be probably missed due to methodological issues ( Figure S3C ). However, the immunoblot-based method (ViraStripe CagA-IgG Blot) was positive in some patients without evidence for past or present H. pylori infection and the lower specificity could be at least in part be the explanation for the higher detection rate (data not shown). anti-CagA-IgG titer were evaluated using ELISA; Statistical analyses were performed using Mann-Whitney test.
DISCUSSION
suggested correlation between cagA gene and seropositivity against CagA, our data showed that only 36%-43% patients had anti-CagA-IgG [22, 23, 32] . In a recent work from Blaser´s group, the prevalence of anti-CagA-IgG in a large cohort of children in Europe was 32% [33] . The data from those studies confirm the low seropositivity in a European population with seropositivity for anti-CagA-IgG of microbiologically confirmed H. pylori cagA+ infected subjects.
Experience from H. pylori vaccine trials suggests that an immune response to CagA is a common event.
In the phase-Ⅰ vaccine trials, intramuscular application of CagA, VacA and NAP induced strong systemic immune reactions measured via anti-CagA-IgG [34] . So, basically any contact of inflammatory cells with CagA leads to antibody production in B-lymphocytes following antigen presentation. The failure in CagA presentation may happen during various steps of infection such as defective CagA expression, missing translocation due to T4SS system or missing or low cell death related to H. pylori infection and according low antigen presentation to immune cells. Indeed, the majority of H. pylori strains from subjects with anti-CagA-IgG exhibited mRNA expression in vitro, while a subgroup of bacteria showed no or very low cagA mRNA expression which further correlated with CagA protein expression the in vitro AGC cell model. However, multiple factors related to host and environment (for example low acidity, predisposition to inflammation) may play very important role [35] . Using in vitro model, we confirmed that the inflammatory potential of cagA positive strain was confirmed in vitro using the classical co-cultivation model of AGS cells and using CagA expression analysis in AGS cells (Table 3) . To the first, direct analyses of strains with anti-CagA-IgG seropositivity did not reveal significant difference in inflammatory potential measured by IL-8 in vitro, suggesting that other bacterial factors could contribute to immune reaction. Second, co-cultivation analysis using AGC cells confirmed from mRNA expression showing that the multiple H. pylori strains from patients with negative anti-CagA-IgG have fully functional CagA and TSS4 (Table 3) .
Increasing evidence highlights the role of vacA polymorphisms in gastric diseases [26] . Assessment of H. pylori vacA and cagA genotypes and serological host response earlier revealed the association with vacA s1 [25] . Systematic analyses of vacA subtypes in background of anti-CagA-IgG have revealed crucial dependency of seropositivity on H. pylori vacA s1m1 polymorphism in our cohort. The in vitro data highlight the inflammatory potential of H. pylori strains with vacA s1m1 polymorphism. This observation is further supported by data showing the dependency of apoptotic activity of H. pylori on vacA [36] . This led us to believe that the immune response to cagA may be at least in part triggered by the effect of VacA on the gastric mucosa. Therefore, the amount of inflammation related to cell toxicity and apoptosis through VacA may influence the interaction of cellular CagA with the immune system and ultimately determine the immune response. The interaction between VacA and CagA has been in focus of several recent studies providing evidence for complex interaction and showing that VacA and CagA can counter-regulate or antagonize each other and affect the host-bacteria interaction [37, 38] . Whether a host will develop an immune response to an infection may be influenced by multiple factors. The seroprevalence may typically change during the course of infection, however, it only partially true for H. pylori infection that shows relatively similar pattern during the life-time starting with early infection to death. We have previously shown that anti-CagA-IgG seropositivity was similar in different age groups (above or below 30 years) from H. pylori positive subjects [22] . Recently, the similar serological pattern was shown in children, where anti-CagA-IgG was positive in 32% despite the very young age [33] . Based on this observation, we speculate that the initial Infection with H. pylori and according very first contact to CagA may determine the serological status of the host, which will then remain stable through the whole life until H. pylori treatment, disappearance or death. In this regard, the host factors and especially genetic predisposition may play the very important role. Certain host factors such as genetic polymorphism (exp. HLA) have previously been suggested to be associated with susceptibility or resistance to H. pylori infection [39] . Furthermore, nonfunctional TLR1 SNP 602S/S has been associated with a reduced risk of H.pylori-induced gastritis [40] . Also, a genome-wide association study identified an association between TLR1 and H. pylori seroprevalence that could potentially explain the variation [41] . However, TLR1 is not the only candidate gene, and IL1-beta 
GCA/PUD
should be also considered as a potential determinant [42] . From the clinical perspective, our data support significant association of H. pylori CagA seropositivity and corpus predominant gastritis, atrophic alterations in gastric mucosa. However, the absence of anti-CagAIgG does not preclude the infection of individual with the more virulent CagA positive H. pylori strain. Based on the current data, the knowledge of individual antiCagA-IgG status does not allow any specific prognostic clinically-relevant management in support of existing recommendation [43, 44] . One of the limitations of our study is that due to the low number of patients, we were unable to suitably address the host related genetic factors. In the present study, we focused on the systemic anti-CagA-IgG production and the locally produced IgA response may be an interesting target for evaluation. Even though we could correlate CagA-IgG data from two different tests, there still may be some difference related to different techniques [25] . Nevertheless, we observed the best specificity with the ELISA kit while immunoblot although had slightly higher sensitivity, it was also associated with high number of false positive results (data not shown). Furthermore, even though the H. pylori CagA-IgG positive and negative groups were well balanced, the higher number of subjects were female and potential gender specificity cannot be fully excluded.
In summary, we show that seropositivity for CagA in subjects with H. pylori infection is positive in one third of H. pylori infected European population despite the presence of CagA positive strain. The immune response to CagA was associated with various bacterial factors and most importantly with H. pylori vacA gene polymorphisms. Our data support a crucial role of bacterial and probably host-related factors that codetermine the complex interaction with H. pylori and define the immunologic and clinical phenotypes of the infection.
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Background
Helicobacter pylori (H. pylori) -related peptic ulcer disease and gastric adenocarcinoma are commonly associated with cagA+ H. pylori strains. However, seropositivity against CagA varies among different studies with positivity below 50% in multiple studies from Europe.
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Infection with H. pylori induces strong and sustained inflammation in mucosa and triggers immune positivity against H.pylori. Although similar immune response to CagA is expected for H. pylori cagA+ strains, the positivity is substantially lower. The mechanism responsible for the seropositivity to CagA is not sufficiently understood. This knowledge may be helpful to identify the factors responsible for the differences in clinical phenotype of H. pylori infection. Furthermore, it may also facilitate the preventive and treatment strategies.
Innovations and breakthroughs
In this well-characterized cohort of patients, we demonstrated a low anti-CagAIgG positivity in H. pylori infected patients, which was independent to the high rate of H. pylori cagA positive strains. Immune response to H. pylori CagA was strongly associated with atrophic gastritis, increased mucosal inflammation and IL-8 expression. Most importantly, we observed a strong association of antiCagA positivity to H. pylori vacA s and m polymorphisms, which also correlated with the inflammatory potential in vitro in AGS cell lines. Altogether, our data suggest that H. pylori vacA polymorphism may determine the immune response to CagA through modulation of mucosal inflammation.
Applications
These data strengthens the role of H. pylori vacA polymorphisms and immune response to CagA and in H. pylori infection. Whether H. pylori vacA may become a clinical tool for risk stratification of H. pylori-related diseases needs further evaluation.
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The results in this manuscript have demonstrated that seropositivity for CagA in subjects with CagA positive H. pylori status is present in one third of H. pylori infected European population. The immune response to CagA is associated with various bacterial factors and most importantly with vacA gene polymorphisms. The data supported that both bacterial and host-related factors determined the complex interaction of H. pylori with the immunologic system and clinical phenotypes of the infection.
